Mission
ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
Staff Only
| Washington state makes coverage decision based on ICER review |
| In January, 2008 the ICER appraisal of CT colonography (“virtual colonoscopy”) was presented to the Washington state Health Care Authority (HCA) and used as the basis of its coverage decision for the state Medicaid program, VA, state employees, and department of corrections. The Washington state HCA voted that its judgment concurred with the ICER rating of comparative clinical effectiveness: CT colonography was “comparable” to optical colonoscopy; coverage was denied, however, on the basis of poor comparative value. This judgment was guided by results of Washington state reimbursement figures entered into the ICER economic model. The ICER appraisal is available online at our website. For further information about the Washington state HCA and its coverage decision on CTC, visit http://www.hta.hca.wa.gov/vc.html |